Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $23.9800 (-4.77%) ($23.9800 - $23.9800) on Fri. Nov. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.66% (three month average) | RSI | 14 | Latest Price | $23.9800(-4.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.6% a day on average for past five trading days. | Weekly Trend | TGTX declines -15.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(70%) ARKG(66%) IBB(64%) ARKK(62%) IWO(61%) | Factors Impacting TGTX price | TGTX will decline at least -1.83% in a week (0% probabilities). VIXM(-49%) VXX(-41%) UUP(-19%) UNG(-6%) TLT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.83% (StdDev 3.66%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $0.68(-97.16%) | Resistance Level | $29.52 | 5 Day Moving Average | $24.41(-1.76%) | 10 Day Moving Average | $25.81(-7.09%) | 20 Day Moving Average | $29.52(-18.77%) | To recent high | -32.6% | To recent low | 0.2% | Market Cap | $3.037b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |